179 related articles for article (PubMed ID: 25284284)
1. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
2. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
Outzen M; Tjønneland A; Hughes DJ; Jenab M; Frederiksen K; Schomburg L; Morris S; Overvad K; Olsen A
Int J Cancer; 2021 Feb; 148(4):876-883. PubMed ID: 32838475
[TBL] [Abstract][Full Text] [Related]
3. Association of Selenoprotein and Selenium Pathway Genotypes with Risk of Colorectal Cancer and Interaction with Selenium Status.
Fedirko V; Jenab M; Méplan C; Jones JS; Zhu W; Schomburg L; Siddiq A; Hybsier S; Overvad K; Tjønneland A; Omichessan H; Perduca V; Boutron-Ruault MC; Kühn T; Katzke V; Aleksandrova K; Trichopoulou A; Karakatsani A; Kotanidou A; Tumino R; Panico S; Masala G; Agnoli C; Naccarati A; Bueno-de-Mesquita B; Vermeulen RCH; Weiderpass E; Skeie G; Nøst TH; Lujan-Barroso L; Quirós JR; Huerta JM; Rodríguez-Barranco M; Barricarte A; Gylling B; Harlid S; Bradbury KE; Wareham N; Khaw KT; Gunter M; Murphy N; Freisling H; Tsilidis K; Aune D; Riboli E; Hesketh JE; Hughes DJ
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31027226
[TBL] [Abstract][Full Text] [Related]
4. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
[TBL] [Abstract][Full Text] [Related]
5. Selenoproteins of the Human Prostate: Unusual Properties and Role in Cancer Etiology.
Diamond AM
Biol Trace Elem Res; 2019 Nov; 192(1):51-59. PubMed ID: 31300958
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study.
Hughes DJ; Schomburg L; Jenab M; Biessy C; Méplan C; Moskal A; Sun Q; Demircan K; Fedirko V; Weiderpass E; Mukhtar M; Olsen A; Tjønneland A; Overvad K; Schulze M; Nøst TH; Skeie G; Olsen KS; Ricceri F; Grioni S; Palli D; Masala G; Tumino R; Pasanisi F; Amiano P; Colorado Yohar SM; Agudo A; Sánchez MJ; Ardanaz E; Sund M; Andersson A; Perez-Cornago A; Travis R; Heath AK; Dossus L
Free Radic Biol Med; 2023 Nov; 209(Pt 2):381-393. PubMed ID: 37923090
[TBL] [Abstract][Full Text] [Related]
7. Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.
Yarmolinsky J; Bonilla C; Haycock PC; Langdon RJQ; Lotta LA; Langenberg C; Relton CL; Lewis SJ; Evans DM; ; Davey Smith G; Martin RM
J Natl Cancer Inst; 2018 Sep; 110(9):1035-1038. PubMed ID: 29788239
[TBL] [Abstract][Full Text] [Related]
8. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model.
Diwadkar-Navsariwala V; Prins GS; Swanson SM; Birch LA; Ray VH; Hedayat S; Lantvit DL; Diamond AM
Proc Natl Acad Sci U S A; 2006 May; 103(21):8179-84. PubMed ID: 16690748
[TBL] [Abstract][Full Text] [Related]
9. Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.
Allen NE; Travis RC; Appleby PN; Albanes D; Barnett MJ; Black A; Bueno-de-Mesquita HB; Deschasaux M; Galan P; Goodman GE; Goodman PJ; Gunter MJ; Heliövaara M; Helzlsouer KJ; Henderson BE; Hercberg S; Knekt P; Kolonel LN; Lasheras C; Linseisen J; Metter EJ; Neuhouser ML; Olsen A; Pala V; Platz EA; Rissanen H; Reid ME; Schenk JM; Stampfer MJ; Stattin P; Tangen CM; Touvier M; Trichopoulou A; van den Brandt PA; Key TJ;
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27385803
[TBL] [Abstract][Full Text] [Related]
10. Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.
Kristal AR; Till C; Song X; Tangen CM; Goodman PJ; Neuhauser ML; Schenk JM; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1494-504. PubMed ID: 24732629
[TBL] [Abstract][Full Text] [Related]
11. GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.
Margalit DN; Jordahl KM; Werner L; Wang X; Gwo-Shu Lee M; Penney KL; Batista JL; Martin NE; Chan JM; Kantoff PW; Stampfer MJ; Nguyen PL; Mucci LA
Clin Genitourin Cancer; 2015 Aug; 13(4):370-377.e1. PubMed ID: 25662905
[TBL] [Abstract][Full Text] [Related]
12. Interactions between genes involved in the antioxidant defence system and breast cancer risk.
Oestergaard MZ; Tyrer J; Cebrian A; Shah M; Dunning AM; Ponder BA; Easton DF; Pharoah PD
Br J Cancer; 2006 Aug; 95(4):525-31. PubMed ID: 16868544
[TBL] [Abstract][Full Text] [Related]
13. Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.
Lophatananon A; Stewart-Brown S; Kote-Jarai Z; Olama AAA; Garcia SB; Neal DE; Hamdy FC; Donovan JL; Giles GG; Fitzgerald LM; Southey MC; Pharoah P; Pashayan N; Gronberg H; Wiklund F; Aly M; Stanford JL; Brenner H; Dieffenbach AK; Arndt V; Park JY; Lin HY; Sellers T; Slavov C; Kaneva R; Mitev V; Batra J; Spurdle A; Clements JA; ; ; Easton D; Eeles RA; Muir K
Br J Cancer; 2017 Aug; 117(5):734-743. PubMed ID: 28765617
[TBL] [Abstract][Full Text] [Related]
14. Selenium in Prostate Cancer: Prevention, Progression, and Treatment.
Jiang J; Chen B; Tang B; Wei Q
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765058
[TBL] [Abstract][Full Text] [Related]
15. Boosting and lassoing new prostate cancer SNP risk factors and their connection to selenium.
Booth DE; Gopalakrishna-Remani V; Cooper ML; Green FR; Rayman MP
Sci Rep; 2021 Sep; 11(1):17877. PubMed ID: 34504230
[TBL] [Abstract][Full Text] [Related]
16. The Association Between Selenium, Selenoprotein P (SEPP1), Fluid Intelligence, and Exercise in the UK Biobank Cohort.
Lehrer S; Rheinstein PH
Cureus; 2022 May; 14(5):e25353. PubMed ID: 35651983
[TBL] [Abstract][Full Text] [Related]
17. Selenium supplementation and prostate cancer mortality.
Kenfield SA; Van Blarigan EL; DuPre N; Stampfer MJ; L Giovannucci E; Chan JM
J Natl Cancer Inst; 2015 Jan; 107(1):360. PubMed ID: 25505227
[TBL] [Abstract][Full Text] [Related]
18. Do environmental factors modify the genetic risk of prostate cancer?
Loeb S; Peskoe SB; Joshu CE; Huang WY; Hayes RB; Carter HB; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):213-20. PubMed ID: 25342390
[TBL] [Abstract][Full Text] [Related]
19. Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database.
Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2349-56. PubMed ID: 25304929
[TBL] [Abstract][Full Text] [Related]
20. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
